Literature DB >> 20567588

Skin rash during chronic hepatitis C therapy.

Chandra Veluru1, Dileep Atluri, Rajagopal Chadalavada, Elke Burns, Kevin D Mullen.   

Abstract

Entities:  

Year:  2010        PMID： 20567588      PMCID： PMC2886494     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  9 in total

Review 1.  Side effects of therapy of hepatitis C and their management.

Authors:  Michael W Fried
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.

Authors:  E Savk; G Uslu; A O Karaoğlu; N Sendur; G Karaman
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-05       Impact factor: 6.166

3.  Photoallergic skin reaction to ribavirin.

Authors:  D Stryjek-Kaminska; F Ochsendorf; C Röder; M Wolter; S Zeuzem
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

4.  Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients.

Authors:  O Dereure; N Raison-Peyron; D Larrey; F Blanc; J-J Guilhou
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

5.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

6.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

7.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Authors:  Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moises Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

8.  Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.

Authors:  Yuki Hashimoto; Hiromi Kanto; Masatoshi Itoh
Journal:  J Dermatol       Date:  2007-08       Impact factor: 4.005

9.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245
  9 in total
  4 in total

1.  Hepatitis C Virus Therapy-related Skin Manifestations.

Authors:  Brett E Fortune; Shayla Francis; Lisa M Forman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-05

Review 2.  New treatments for chronic hepatitis C: an overview for paediatricians.

Authors:  Daniele Serranti; Giuseppe Indolfi; Massimo Resti
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 3.  Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach.

Authors:  Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2012-07-26       Impact factor: 9.079

Review 4.  The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.

Authors:  Christine Hong Ting Yang; Eric R Yoo; Aijaz Ahmed
Journal:  J Clin Transl Hepatol       Date:  2017-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.